RADLogics

our rapidly-developed AI-based image analysis can achieve high accuracy in detection of coronavirus as well as quantification and tracking of disease burden, said RADLogics’ CEO and Co-Founder Moshe Becker

BOSTON and TEL AVIV (PRWEB)
March 24, 2020

RADLogics™ announced today new research that validates the performance of an AI-powered CT image analysis solution that is designed to automatically and accurately detect COVID-19 (Coronavirus) and quantify the disease burden in affected patients. To meet the growing worldwide pandemic, RADLogics also announced that it has rapidly deployed this new CT image analysis algorithm, which helps classify results for patients with COVID-19 per thoracic CT studies utilizing deep-learning image analysis.

“As the novel coronavirus continues to rapidly spread around the world, healthcare systems and providers may become overwhelmed with symptomatic patients that require testing, imaging, and treatment,” said RADLogics’ CEO and Co-Founder Moshe Becker. “In an effort to help alleviate this burden on the world’s healthcare providers – and to support improved patient outcomes – we dedicated our resources toward successfully modifying and adapting our existing AI models to develop this solution specifically for COVID-19 detection and quantification. To date, we have already deployed our solution in China, Russia and Italy, and we are rapidly scaling in other countries in response to the strong demand.”

The study, led by Professor Hayit Greenspan from Tel Aviv University and RADLogics, in collaboration with medical experts from the US and China including Dr. Eliot Siegel of the University of Maryland School of Medicine in Baltimore, MD; and Dr. Adam Bernheim of the Icahn School of Medicine at Mount Sinai in New York, NY; found that the CT image analysis algorithm – developed from multiple international datasets – was able to differentiate 157 patients with and without COVID-19 with a 0.996 AUC (plus, 98.2 percent sensitivity and 92.2 percent specificity). Although it is not recommended as a first-line test, non-contrast thoracic CT has been shown to be an effective tool in the detection, quantification, and follow-up of COVID-19. Thus, in addition to detecting and quantifying disease burden, RADLogics’ image analysis further outputs a suggested “Corona Score,” which measures the percentage of lung volume that is infected by disease.

A consistent and reproducible method for rapidly screening and evaluating high volumes of thoracic CT imaging studies can assist healthcare systems through this pandemic by augmenting radiologists and acute care teams that could be overwhelmed with patients. Additionally, with a greater volume of patients who must be screened for coronavirus, earlier and more rapid detection of positive cases can help improve both the treatment of patients and containment of virus spread.

“This study validates our novel solution, which has been widely studied via multiple international datasets and a range of retrospective experiments to analyze the performance over time,” added Becker. “The conclusion was clear: our rapidly-developed AI-based image analysis can achieve high accuracy in detection of coronavirus as well as quantification and tracking of disease burden.”

Results of this study are available on arXiv.org, and it has been submitted to the Radiology Society of North America (RSNA) for review and potential publication in Radiology: Artificial Intelligence. RADLogics is also expanding the initial study to a larger population.

For more information on the RADLogics AI solution for detecting COVID-19, visit our dedicated site at radlogics.com/coronavirus or contact lynn@radlogics.com.

About RADLogics

A healthcare software company developing artificial intelligence (AI)-powered solutions, RADLogics provides machine learning image analysis solutions to improve radiologists’ productivity while enhancing patient outcomes. Based in Boston, MA, US, and Tel Aviv, Israel, RADLogics is one of the pioneers in using AI & machine learning image analysis and advanced big data analytics to search and analyze imaging data from CTs, MRIs, PET scans, and X-rays to help reduce diagnostics turnaround time from hours to minutes by automating detection and report generation functions. The company’s patented AI medical image analysis platform enables rapid development of AI algorithms, and provides seamless integration into existing radiology workflow. Visit http://www.radlogics.com to learn more or follow us on LinkedIn or Twitter.

Share article on social media or email:

Microderm GLO Diamond Microdermabrasion System

Microderm GLO is passionate on bringing traditionally expensive, in-office, professional dermatologist care into everyone’s home.

CHICAGO (PRWEB)
March 25, 2020

Inc. magazine today revealed that Microderm GLO is No. 5 on its inaugural Inc. 5000 Series: Midwest list, the most prestigious ranking of the fastest-growing private companies in Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most successful companies within the Midwest economy’s most dynamic segment—its independent small businesses.

“Not only is it very exciting but it is also a tremendous honor to be ranked in the top 2% of the fastest growing companies in the Midwest by Inc.,” says Microderm GLO founder and CEO Sid Param, “It would have been impossible to reach this point without the dedication of many important people – the relentlessness of our team, the trust and voice of our raving fans, and the inspiration and mentorship from organizations that have recognized and supported us over the years.”

The companies on this list show stunning rates of growth across all industries in the 12 Midwest states. Between 2016 and 2018, these 250 private companies had an average growth rate of 360 percent and, in 2018 alone, they employed more than 27,000 people and added $13 billion to the Midwest’s economy. Companies based in the Chicago, Detroit, and Cincinnati areas brought in the highest revenue overall.

Complete results of the Inc. 5000 Series: Midwest, including company profiles and an interactive database that can be sorted by industry, metro area, and other criteria, can be found at inc.com/inc5000-series-midwest-2020 starting March 25, 2020.

“The companies on this list demonstrate just how much the small-business sector impacts the economies of each Midwest state,” says Inc. editor in chief Scott Omelianuk. “Across every single industry, these businesses have posted revenue and growth rates that are beyond impressive, further proving the tenacity of their founders and CEOs.”

About Microderm GLO

Microderm GLO develops, manufactures, and markets professional-grade, dermatological and healthcare products. On a mission to help people look and feel their best every day, Microderm GLO is passionate on bringing traditionally expensive, in-office, professional dermatologist care into everyone’s home.

While customers choose Microderm GLO for their award-winning, breakthrough skincare products, they stay for the company’s uncompromising commitment to world-class customer happiness and industry-leading lifetime warranty on every product.

For more information about Microderm GLO, visit us at MicrodermGLO.com or connect with us on Facebook and Instagram.

Contact:

Microderm GLO Skincare

Media & PR Department

media@microdermglo.com

888-745-7333

More About Inc. and the Inc. 5000 Regional Series

Methodology

The 2020 Inc. 5000 Regional Series is ranked according to percentage revenue growth when comparing 2016 and 2018. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2018. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2018 is $1 million. As always, Inc. reserves the right to decline applicants for subjective reasons.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

Share article on social media or email:

Meridian Clinical Research Logo

“We’re fully prepared to address any COVID-19 opportunity and support novel research and development programs. Our clients can expect Meridian to be fully staffed and operational throughout this pandemic.”

OMAHA, Neb. (PRWEB)
March 24, 2020

Meridian Clinical Research, a leading investigative research network, will remain open to support the research of investigational tests, vaccines, and medications intended for commercial release.

Meridian sites are working with Sponsors and contract research organizations (CROs) to ensure patient safety while continuing to enroll patients during the COVID-19 pandemic. The company has enrolled more than 25,000 subjects into vaccine and infectious disease clinical trials in the past 20 years. Nicole Osborn, CEO, says Meridian has always focused on protecting healthy participants and patients with acute conditions.

“We’re fully prepared to address any COVID-19 opportunity and support novel research and development programs,” said Osborn. “Our clients can expect Meridian to be fully staffed and operational throughout this pandemic. Our patients can be confident that every Meridian site is meeting and exceeding safety standards, and that we’re operating in line with state-specific regulations.”

To maintain proper social distancing, Meridian is supporting over-the-phone visits, telemedicine visits, and in-office visits with minimal exposure to others and intensified cleaning processes. In early March, Meridian began restricting work-related travel and in-person meeting attendance.

As a leading investigative site network for vaccine trials, Meridian has conducted first-in-human studies for emerging diseases. In 2015, the company supported a Phase I study for the Ebola vaccine when the outbreak occurred, and conducted research for Zika virus and anthrax vaccines in the past year.

Headquartered at its dedicated research center in Omaha, Nebraska, the company operates additional sites in Nebraska (Norfolk), Georgia (Savannah), Louisiana (Baton Rouge), Maryland (Rockville), New York (Binghamton, Endwell, Johnson City, Vestal), South Dakota (Dakota Dunes), and Virginia (Norfolk).

Sponsors and CROs interested in leveraging Meridian’s network for infectious disease trials should contact Andrew Kimball, vice president, business development, at akimball@mcrmed.com.

“We’re here to educate patients and people interested in the research process,” said Osborn. “The spread of COVID-19 gives us a chance to engage and inform more people about the importance of clinical research to address viruses like SARS-CoV-2.”

Patients who are currently enrolled in a Meridian trial are encouraged to call the site they’re visiting or the Meridian call center: (402) 934-7563 (LA, NE, SD) • (912) 623-2240 (GA, MD, NY, VA).

Visit mcrmed.com/vaccine to learn more about Meridian’s infectious disease capabilities. To view current studies and sign up to learn about new opportunities at Meridian’s locations across the U.S., visit mcrmed.com.

ABOUT MERIDIAN CLINICAL RESEARCH

Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new pharmaceutical drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is headquartered at a dedicated research center in Omaha, NE, and conducts Phase I-IV studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials. For more information, visit http://www.mcrmed.com.

Share article on social media or email:

We are dedicated to helping patients get access to care more quickly, and to working with medical heroes on the front lines to navigate through this global health crisis.

SAN FRANCISCO (PRWEB)
March 25, 2020

Luma Health https://www.lumahealth.io/, the leader in total patient engagement, today announced it has granted healthcare providers free 30-day access to its broadcast messaging product through April 30, to dramatically improve clinicians’ ability to get the right message and information out to patients to address fears, concerns, and false information as the world navigates COVID-19. In addition, for pre-screened patients or those with high-risk profiles for experiencing complications from the disease, Luma Health is offering a free 90-day trial for telehealth virtual visits to help reduce non-critical patient visits and unnecessary exposure for patients and care providers.

To sign up for the free broadcast patient communications, visit http://www.lumahealth.io/covid-19-patient-messaging.

The spread of the COVID-19 virus has created enormous challenges for clinics, hospitals, and healthcare systems across the United States, particularly in reaching patients with the most relevant information and access to care. A growing number of healthcare systems and clinics, including UCSF Health, UCSD Health, Salud Health Centers, Prima Care, Zufall Health Centers and many others are using Luma Health to reach their patients. In just this past week, Luma Health has helped over 80 clinics and systems reach their patient populations with COVID-19 related messages, potentially impacting and helping millions of patients across the U.S.

Key capabilities to Luma Health’s broadcast messaging solution include:

Uploading lists of patients directly from an organization’s electronic health record [EHR] system, taking less than a day for clinics and systems to implement.

Pre-built templates for COVID-19 patient messaging that can be customized to meet the needs of specific clinics, as well as an online questionnaire (https://bit.ly/covid-template) to help healthcare providers screen patients to determine if they require further testing.

Rapid and efficient targeting of select groups or entire populations with vital messaging related to their healthcare, such as informing high-risk patients about added precautions to help limit the spread of COVID-19.

“In the war on COVID-19, it is critically important that healthcare professionals can communicate with their patients and provide them with vital information that will help protect their health and save lives,” said Dr. Tashfeen Ekram, Co-founder and Chief Medical Officer at Luma Health. “We are dedicated to helping patients get access to care more quickly, and to working with medical heroes on the front lines to navigate through this global health crisis.”

Clinicians can utilize Luma Health’s Collaboration Hub to coordinate pre-scheduled and on-demand telehealth virtual visits by opening a virtual exam room using Luma Health’s 90-day televisit trial.

To further assist care providers as they begin to become stretched with an increasing number of at-risk patients, Luma Health has compiled a COVID-19 Best Practices for Patient Communication guide (http://www.lumahealth.io/blog/coronavirus-patient-communication-best-practices) to help providers navigate this challenging time.

To learn more about the Luma Health platform, visit http://www.lumahealth.io/platform.

About Luma Health

Luma Health was founded on the idea that healthcare should work better for all patients. Every single point along the care journey should be simple, seamless, and effective, from accessing care to achieving health goals. Luma Health empowers providers to make this a reality through its total patient engagement solution, designed to boost access, streamline patient-provider communications, and help providers grow their business.

Headquartered in San Francisco, Luma Health’s platform is modernizing communication by delivering smarter conversations that drive patient engagement and continuous care, empowering thousands of providers and more than 11 million patients across the United States today. Additional information about the company is available at https://www.lumahealth.io/, https://blog.lumahealth.io/, https://www.linkedin.com/company/lumahealth/, https://www.facebook.com/lumahealth, and https://twitter.com/lumahealthhq.

For media inquiries, please contact:

Alan Tam

Luma Health

(415) 741-3377

alan@lumahealth.io

Share article on social media or email:

Community Connect enables residents to self-report COVID-19 and high-risk occupant information in minutes – shared directly with Emergency Services for a more prepared response.

With this information at their fingertips, firefighters and EMS personnel will have a much clearer picture of who they are responding to and what their health situation is. — Fire Chief Gary Ludwig, IAFC President and Chairman of the Board.

NEW YORK (PRWEB)
March 25, 2020

First Due, known to Public Safety agencies across the US for developing next-generation pre-incident planning, mobile response, and community engagement solutions, announced today, in partnership & collaboration with the International Association of Fire Chiefs, a FREE version of their Community Connect platform, in order to help Fire-EMS, Police, Emergency Management, and Healthcare agencies better combat the COVID-19 pandemic.

Community Connect is currently used nationwide, enabling citizens to share critical life safety details of their households and businesses with their respective Public Safety agencies. With the ensuing COVID-19 Health Crisis developing across the United States, First Due has released a COVID-19 focused version of Community Connect, designed to allow residents to self-report their status and take protective actions during the outbreak. Agencies can use this information at the time of response or analyze the data in GIS platforms such as Esri’s ArcGIS.

“This tool will allow fire and EMS agencies the ability to know better where citizens have self-isolated or self-quarantined themselves in their community. With this information at their fingertips, firefighters and EMS personnel will have a much clearer picture of who they are responding to and what their health situation is. The IAFC is pleased to partner with innovative companies and technologies that help provide better, faster, and more capable services for our communities. We are pleased to partner with First Due.” — Fire Chief Gary Ludwig, IAFC President and Chairman of the Board.

Community Connect for COVID-19 offers residents an easy-to-use web portal, available on any device, where they can self-report critical information in line with industry protocol. Within the web portal, residents will be able to share contact, symptom, test, and high-risk related information. Shared information will then be available to First Responders to better prioritize COVID-19 driven care or take proper precautions before entering. Additionally, data collected from residents will be made actionable across GIS applications, such as Esri’s ArcGIS to give Public Safety agencies insight into how the Coronavirus is affecting their community.

“We’ve heard from Public Safety Agencies nationwide how difficult it is to track, manage, and report on current COVID-19 cases in their communities, resulting in First Responder exposures and a lack of situational awareness. Now, more than ever, Emergency Services need this critical information for a more prepared response. For that reason, we ask everyone to take two minutes out of their day to sign up and self-report!” explains Andreas Huber, First Due’s Co-Founder & CEO.

Community Connect for COVID-19 is designed for the sole mission of improving emergency response and community risk area analysis. Data shared via the platform will not be used for any other purpose and is 100% secure featuring bank-level encryption and security standards.

If you are a Public Safety agency and would like to receive First Responder Access to the system, please visit https://www.firstduesizeup.com/communityconnect/covid19 to create your FREE account.

Self-Reporting will be open to the public on Friday the 27th of March at 3:00 PM EST following a formal announcement by First Due.

ABOUT FIRST DUE:

First Due is a public safety software company based in New York City and backed by Teamworthy Ventures, TechNexus, Collate Capital, New York Angels and HBSAANY. First Due’s cloud-based First Responder safety and situational awareness platform re-imagines Pre-Incident Planning, Emergency Response and Community Engagement for public safety agencies nationwide. By automating the aggregation of disparate data sources, and providing powerful planning, mapping and community engagement tools; public safety agencies finally have actionable data on every structure for every call in a format they can consume in seconds.

Departments utilizing First Due such as Seattle, Ft. Lauderdale, Charlotte, and Fort Worth, have the data they need for better decisions before, during and after incidents – leading to more positive outcomes.

To request more information regarding First Due’s products or to get in touch with First Due’s executive team, please visit https://firstduesizeup.com/.

First Due Media Contact:

Ron Kanter

Head of Growth

+1 (516) 874-2258

ron@firstduesizeup.com

ABOUT THE INTERNATIONAL ASSOCIATION OF FIRE CHIEFS:

The IAFC represents the leadership of firefighters and emergency responders worldwide. IAFC members are the world’s leading experts in firefighting, emergency medical services, terrorism response, hazardous materials spills, natural disasters, search and rescue, and public safety legislation. Since 1873, the IAFC has provided a forum for its members to exchange ideas, develop professionally and uncover the latest products and services available to first responders.

IAFC Media Contact:

Jim Philipps

Assistant Director, Strategic Communications

jphilipps@iafc.org

703-537-4829

Share article on social media or email:

AANP logo

Serving in primary and specialty care, NDs are ready, willing, and able to support other medical professionals in changing the trajectory of this public health crisis.

WASHINGTON (PRWEB)
March 25, 2020

The American Association of Naturopathic Physicians (AANP), representing 8,000 licensed naturopathic doctors (NDs) in the United States, encourages all government officials coordinating the national response to the 2019 Novel Coronavirus Pandemic (COVID-19) to to utilize all licensed healthcare professionals in this health emergency, including NDs. Licensed NDs work collaboratively across all forms of medicine, and in regulated states are already integrated into health systems. Serving in primary and specialty care, NDs are ready, willing, and able to support other medical professionals in changing the trajectory of this public health crisis.

Health literacy and patient education are central components of the naturopathic doctor’s approach to patient-centered care. Many current public health practices and lifestyle recommendations are foundational principles of naturopathic medicine and inform our approach to support public health efforts through this current pandemic. We stand in solidarity with our colleagues at the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and State and Local governments in promoting essential public health measures to reduce the burden on U.S. and global healthcare systems.

We call on Federal, State and Local authorities to engage naturopathic doctors in emergency measures to supplement the healthcare workforce during this crisis, recognizing:

• NDs are trained comparably to conventional doctors to diagnose and triage according to presenting symptoms, refer to the appropriate level of care, and support patients during at-home symptom management.
• NDs practice patient-centered medicine and tailor personalized care plans. In addition to all public health recommendations, NDs employ a toolkit of treatment approaches that can be used to support the body’s inherent immune capacity to prevent viral infections, address viral infections directly, ease symptoms in those infected, and support recovery during post-infection care.

Further, we recommend the following actions be taken to empower licensed naturopathic doctors to promote the health and safety of those at highest risk:

• Increase access to care: Licensed NDs can serve in states that have declared states of emergency and are calling for volunteer healthcare practitioners to prevent their healthcare systems from becoming overwhelmed.
• Increase access to Telemedicine services: We call on insurance providers who currently cover the services of licensed NDs to cover telehealth services provided by NDs, following the recent Telehealth guidelines issued by CMS. This will allow NDs to continue treating patients with chronic diseases or comorbidities that make them more susceptible to SARS-CoV-2, and will allow patients to stay safely at home.
• Expedite research on novel agents: Many agents in the naturopathic medicine toolkit have been shown to have a pharmacological effect on related viruses. Naturopathic doctors are the only licensed health care providers trained in the science and clinical use of these agents. We encourage the rapid exploration and study of novel agents that may serve to slow the progression of this particular pandemic, inclusive of relevant research coming out of countries with strong histories of using traditional medicines safely and effectively.

AANP President, Robert Kachko, ND, LAc, stated, “Naturopathic doctors are well-equipped to diagnose and refer to the most appropriate level of care based on clinical presentation and diagnostic staging, supporting continued access to our limited local healthcare resources for our most vulnerable populations. In particular, we encourage those individuals who test positive to the SARS-CoV-2 virus but are instructed by healthcare authorities to self-quarantine at home to receive personalized care from naturopathic doctors via telemedicine.”

The American Association of Naturopathic Physicians and its affiliated organizations will remain a resource to our colleagues in health and medicine, working to limit this pandemic and ensure the continued health and safety of our nation.

About the American Association of Naturopathic Physicians

The American Association of Naturopathic Physicians (AANP) is the professional association that represents licensed naturopathic physicians. AANP strives to make naturopathic medicine available to every American, and to increase recognition of naturopathic physicians as the identified authorities on natural medicine. Learn more at http://www.naturopathic.org.

Share article on social media or email:

CHCQM Board Certified

HCQM Certification is the only health care quality and management certification administered through the National Board of Medical Examiners® (NBME®).

NEW PORT RICHEY, Fla. (PRWEB)
March 25, 2020

(ABQAURP) 24 March 2020 – The importance of health care quality and patient safety is paramount in providing medical care in today’s environment. It is essential that health care providers and administrators demonstrate their expertise and commitment to health care quality and safety. According to ABQAURP Chairman of the Board, Dr. Arthur Broder, “Employers adopting HCQM Certification and education for their medical staff allows them to say to outside interests that they have the highest possible standards for their medical team by certifying them through an independent, non-profit organization (ABQAURP) that is dedicated to ensuring health care quality and management.”

In addition to concerns about patient safety, inappropriate services, and unnecessary readmissions, the rising costs of health care and its impact on families and business all solidify the need for Health Care Quality and Management (HCQM) Certification.

Realizing what a hectic time it is for health care professionals around the world, ABQAURP strives to make certification accessible, therefore the early registration deadline and the extra savings promotion have been extended through April 22, 2020, to allow medical professionals time to concentrate on what’s important now – taking care of family, patients, and staff. ABQAURP humbly thanks you for your tireless efforts during this unprecedented time.

Validate your expertise with a certification that demonstrates knowledge and commitment to safety, health care quality, and effective care. HCQM Certification is a definitive benchmark of achievement signifying a higher level of proficiency; and is the only health care quality and management certification administered through the National Board of Medical Examiners® (NBME®).

ABQAURP continues to deliver the highest quality certification process, bringing examinees a certification based on definable standards upheld by knowledgeable experts.

Health care leaders can enhance their HCQM credential with additional sub-specialty certifications in the following categories:

-Case Management

-Managed Care

-Patient Safety / Risk Management

-Physician Advisor (Physicians Only)

-Transitions of Care

-Workers’ Compensation

The HCQM Examination and Physician Advisor Sub-Specialty are endorsed by the American College of Physician Advisors. HCQM Certification and the physician advisor sub-specialty align with ACPA’s mission to promote and expand the prominent role of the Physician Advisor in today’s rapidly changing health care environment through education, certification, mentorship, and collaboration; as well as ABQAURP’s mission to improve the overall quality of health care provided to the public.

Dr. Charles Locke, President of the American College of Physician Advisors (ACPA), Senior Physician Advisor for The Johns Hopkins Hospital and ABQAURP Diplomate states, “I found the HCQM Certification with Physician Advisor sub-specialty to be invaluable in my development as a physician advisor. The certification process helped broaden and solidify my knowledge in so many areas including health care quality metrics, payer models, and the role of case management.”

Prepare now for the 2020 HCQM Examination! Now accepting applications for the HCQM Test Window that will be open from August 15 through October 15, 2020. The extended Early Registration Discount is now valid through April 22, 2020; register now to save $50 off the HCQM Exam Fee.

As an additional incentive, save up to $150 when using Promo Code: HCQM20PR to save $75 on the Core Body of Knowledge online course and $75 on the HCQM Exam Fee (when used in conjunction with the $50 early registration discount currently in place). Exam candidates do not need to purchase at the same time, but must register for both no later than April 22nd to maximize savings. Promotion cannot be used in conjunction with other offers.

Visit the ABQAURP website at: http://www.abqaurp.org/Certification or call (800) 998-6030 to learn how HCQM Certification can validate your experience and set you apart from the rest!

“National Board of Medical Examiners®” and “NBME®” are registered trademarks of the National Board of Medical Examiners.

About ABQAURP

Celebrating over 40 years of excellence in Health Care Quality Management and Patient Safety, ABQAURP is a premier professional association providing Health Care Quality and Management (HCQM) certification, ACCME-accredited continuing medical education, and membership to health care professionals worldwide. Learn more at: http://www.abqaurp.org.

About the ABQAURP and ACPA Alliance

ABQAURP and ACPA formed the alliance to offer the first Physician Advisor sub-specialty for the HCQM certification. HCQM Certification and the physician advisor sub-specialty align with ACPA’s mission to promote and expand the prominent role of the Physician Advisor in today’s rapidly changing health care environment through education, certification, mentorship, and collaboration; as well as ABQAURP’s mission to improve the overall quality of health care provided to the public.

Share article on social media or email: